STAMBP-IN-1
STAMBP-IN-1 is a small-molecule inhibitor of STAMBP deubiquitinase, and interrupts STAMBP-Ub-NALP7 interaction. STAMBP-IN-1 decreases protein level of its inflammasome substrate NALP7 and suppresses IL-1b release after Toll-like receptor (TLR) agonism. STAMBP-IN-1 inhibits the activity of STAMBP to cleave recombinant di-Ub with an IC50 value of 0.33 mM[1].
Product Specifications
CAS Number
896683-78-6
UNSPSC
12352005
Target
Deubiquitinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/stambp-in-1.html
Purity
98.73
Solubility
DMSO : 3.29 mg/mL (warming; heat to 80°C)
Smiles
O=C(NCC1=CC=CO1)CSC(N2CCC3=CC=CC=C3)=NC4=C(C=C(N5CCOCC5)C=C4)C2=O
Molecular Formula
C27H28N4O4S
Molecular Weight
504.60
References & Citations
[1]Bednash JS, et al. Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun. 2017 May 11;8:15203.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (Fn-3), CF640R conjugate, 0.1mg/mL
Nucleophosmin (Acute Myeloid Leukemia Marker) (NA24), CF647 conjugate, 0.1mg/mL
CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF568 conjugate, 0.1mg/mL
Ep-CAM / CD326 (Epithelial Marker) (rEGP40/1110), CF568 conjugate, 0.1mg/mL
